Co-Diagnostics, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Co-Diagnostics, Inc. (CODX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $3.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $3.65M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $8.23M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $11.88M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $11.44M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $3.65M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.23M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $11.88M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $11.44M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $11.12M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.90M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $2.94M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $10.80M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $13.86M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $23.10M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $14.92M 10-K · filed 2026-03-31 |
| 2023-09-30 | $10.24M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $13.83M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $6.36M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $22.97M 10-K · filed 2025-03-27 |
| 2022-09-30 | $81.51M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $86.05M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $97.42M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $88.61M 10-K · filed 2024-03-14 |
| 2021-09-30 | $82.66M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $70.27M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $57.79M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $42.98M 10-K · filed 2023-03-16 |
| 2020-09-30 | $21.23M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $18.55M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $17.37M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $893.14K 10-K · filed 2022-03-24 |
| 2019-09-30 | $2.54M 10-Q · filed 2020-11-16 |
| 2019-06-30 | $3.86M 10-Q/A · filed 2020-11-03 |
| 2019-03-31 | $5.41M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $950.24K 10-K · filed 2021-03-25 |
| 2018-09-30 | $2.18M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $1.53M 10-Q · filed 2019-08-14 |
| 2017-12-31 | $3.53M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |